10 Participants Needed

Leg Stretching Exoskeleton for Spasticity

SW
Overseen BySteven W Brose
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: VA Office of Research and Development
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

Do I need to stop taking my current medications for the trial?

The trial requires that you do not take medications that affect bone metabolism, muscle strength, or cardiovascular performance. If you are on such medications, you may need to stop them to participate.

What data supports the effectiveness of the treatment Leg Stretching Using an Exoskeleton on Demand for spasticity?

Research shows that stretching can help reduce spasticity (muscle stiffness) and improve movement. An intelligent stretching device for ankles has been effective in increasing range of motion and reducing stiffness, suggesting that similar exoskeleton technology might help with leg spasticity.12345

Is the leg stretching exoskeleton generally safe for humans?

The safety of leg stretching exoskeletons is still being studied, and while they have been approved for use, the risks are not fully understood yet. Reported adverse events and risks vary, and more research is needed to develop safety standards and regulations.23467

How does the leg stretching exoskeleton treatment for spasticity differ from other treatments?

The leg stretching exoskeleton is unique because it uses a robotic device to provide controlled stretching of the legs, which can be adjusted based on the resistance felt during the stretch. This allows for a more precise and potentially more effective treatment compared to traditional manual stretching methods, and it can be used frequently at home or in clinics for long-term improvement.12458

What is the purpose of this trial?

This trial is testing a special leg suit designed to help people with movement problems due to neurological conditions. The suit uses sensors to assist with leg movements and stretching, aiming to improve walking and daily activities.

Research Team

SW

Steven W Brose

Principal Investigator

Syracuse VA Medical Center, Syracuse, NY

Eligibility Criteria

This trial is for veterans with spasticity from a spinal cord injury that's at least 6 months old. They must be stable, able to consent, follow instructions, and not pregnant or recovering from recent surgeries. Participants should weigh under 300 lbs and not have other neurological disorders or conditions affecting mobility.

Inclusion Criteria

I can give consent and share my age, gender, and neurological condition.
I am a veteran with muscle stiffness from a spinal injury that happened over 6 months ago.
Neurologically stable (>6 months post-SCI) and can wear the device and the sensors, provide written informed consent, and follow instruction

Exclusion Criteria

I have a spinal cord injury and no other neurological disorders.
I haven't had hip or knee pain that limits my movement in the last 2-3 weeks.
I am not on medications that affect bone, muscle, heart, or have conditions causing high fever, BP, or heart rate.
See 3 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

1-2 weeks
1 visit (in-person or phone)

Treatment

Participants use the wearable exoskeleton for leg stretching and walking experiments

24 weeks
Multiple visits (in-person)

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

Treatment Details

Interventions

  • Leg Stretching Using an Exoskeleton on Demand
Trial Overview The study tests a wearable robotic exoskeleton designed to improve leg function and walking in people with movement issues due to neurological disorders. It involves exercises like leg stretching and treadmill walking to see how it affects muscle activity, joint motion, and gait.
Participant Groups
1Treatment groups
Experimental Treatment
Group I: Robotic ExoskeletonExperimental Treatment1 Intervention
All participants will be interfered with a wearable robotic exoskeleton.

Find a Clinic Near You

Who Is Running the Clinical Trial?

VA Office of Research and Development

Lead Sponsor

Trials
1,691
Recruited
3,759,000+

Syracuse University

Collaborator

Trials
54
Recruited
118,000+

Findings from Research

Powered exoskeletons, like the ReWalk™, Indego™, and Ekso™, have been approved as medical devices to help individuals with gait disabilities walk upright, but the understanding of their risks and safety is still developing.
There is a significant need for standardized regulations and awareness of potential risks associated with powered exoskeletons to ensure safe and effective use, as current criteria for their use and reported adverse events vary widely.
Risk management and regulations for lower limb medical exoskeletons: a review.He, Y., Eguren, D., Luu, TP., et al.[2020]

References

The effects of stretching in spasticity: a systematic review. [2022]
Feedback-controlled and programmed stretching of the ankle plantarflexors and dorsiflexors in stroke: effects of a 4-week intervention program. [2022]
Influence of posture and muscle length on stretch reflex activity in poststroke patients with spasticity. [2016]
Intelligent stretching of ankle joints with contracture/spasticity. [2007]
Influences of muscle stretch reflexes on voluntary, velocity-controlled movements in spastic paraparesis. [2019]
Risk management and regulations for lower limb medical exoskeletons: a review. [2020]
Supplemental Stimulation Improves Swing Phase Kinematics During Exoskeleton Assisted Gait of SCI Subjects With Severe Muscle Spasticity. [2020]
Computational modeling of neuromuscular response to swing-phase robotic knee extension assistance in cerebral palsy. [2021]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security